This formulation is equivalent to 5 mg/mL anhydrous caffeine.
The neomycin sulfate quantity may need adjustment based upon the assay of the specific lot.
A liquid dosage form usually is necessary for infants and young children requiring this drug.
This preparation has been used to treat seizures, chronic pain, bipolar disorder, and social phobia.
Keep this preparation away from heat and flame.
Although similar to a formerly available commercial product, this preparation contains no cod liver oil.
This compound may be used for bowel preparation before abdominal
surgery and selectively for digestive-tract problems in ICU patients.
This preparation is also suitable for use in children aged 6 years and older.
This high-risk preparation is suitable for the treatment of moderate-to-severe pain.
This preparation may be used to treat hormonal problems in both men and women.
This potent preparation should be applied by a physician, not by a patient or caregiver.
This preparation is suitable for patients who cannot swallow the solid oral form.
This preparation is used as an antiemetic.
Since there is currently a shortage, this product may be compounded to meet patients’ needs.
This drug is approved with restricted distribution for certain cases of erythema nodosum leprosum and multiple myeloma.
This delivery system utilizes a new dosage form.
This topical preparation may be used to treat Raynaud’s phenomenon and progressive diabetic foot ulcers.
This semisynthetic aminoglycoside antibiotic is presently in short supply.
Product shortages and lack of availability may render it necessary for the pharmacist to compound a suitable alternative.
This formulation can be compounded for use until the manufactured product—recently in short supply—is readily available.
For more articles, please check our archives.